Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle: A. Fleckenstein; Ann. Rev. Pharmacol. 17, 149 (1977) Abstract
alpha-adrenergic antagonists as possible calcium channel inhibitors: D. Atlas & M. Adler; PNAS 78, 1237 (1981) Abstract
Effect of trifluoperazine, compound 48/80, TMB-8 and verapamil on the rate of calmodulin binding to erythrocyte Ca2+-ATPase: O. Scharff & B. Foder; Biochim. Biophys. Acta 772, 29 (1984) Abstract
Participation of intracellular sites in the action of Ca2+ channel blockers: E.J. White & H.F. Bradford; Eur. J. Pharmacol. 130, 243 (1986) Abstract
R. Janis, et al.; Adv. Drug Res. 16, 309 (1987)
Goodman and Gilman's The Pharmacological Basis of Therapeutics, vol. 8; p. 774 (1990)
Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex: D. Piwnica-Worms, et al.; Cancer Res. 53, 977 (1993) Abstract
Effect of high-dose verapamil administration on the Ca2+ channel density in rat cardiac tissue: B.B. Lonsberry, et al.; Pharmacology 49, 23 (1994) Abstract
Apoptosis of human primary and metastatic colon adenocarcinoma cell lines in vitro induced by 5-fluorouracil, verapamil, and hyperthermia: I.B. Shchepotin, et al.; Anticancer Res. 14, 1027 (1994) Abstract
Apoptosis induced by hyperthermia and verapamil in vitro in a human colon cancer cell line: I.B. Shchepotin, et al.; Int. J. Hyperthermia 13, 547 (1997) Abstract
Hyperthermia and verapamil inhibit the growth of human colon cancer xenografts in vivo through apoptosis: I.B. Shchepotin, et al.; Anticancer Res. 17, 2213 (1997) Abstract
Neuron degeneration induced by verapamil and attenuated by EGb761: L. Zhu, et al.; J. Basic Clin. Physiol. Pharmacol. 8, 301 (1997) Abstract
|
